Annual CFF
$336.60 M
+$227.51 M+208.56%
31 December 2023
Summary:
Mirum Pharmaceuticals annual cash flow from financing activities is currently $336.60 million, with the most recent change of +$227.51 million (+208.56%) on 31 December 2023. During the last 3 years, it has risen by +$155.31 million (+85.67%). MIRM annual CFF is now at all-time high.MIRM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$3.86 M
-$3.43 M-47.02%
30 September 2024
Summary:
Mirum Pharmaceuticals quarterly cash flow from financing activities is currently $3.86 million, with the most recent change of -$3.43 million (-47.02%) on 30 September 2024. Over the past year, it has dropped by -$203.27 million (-98.13%). MIRM quarterly CFF is now -98.13% below its all-time high of $207.13 million, reached on 30 September 2023.MIRM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$14.14 M
-$203.27 M-93.50%
30 September 2024
Summary:
Mirum Pharmaceuticals TTM cash flow from financing activities is currently $14.14 million, with the most recent change of -$203.27 million (-93.50%) on 30 September 2024. Over the past year, it has dropped by -$320.36 million (-95.77%). MIRM TTM CFF is now -95.80% below its all-time high of $336.60 million, reached on 31 December 2023.MIRM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MIRM Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +208.6% | -98.1% | -95.8% |
| 3 y3 years | +85.7% | +1019.7% | -93.2% |
| 5 y5 years | - | -94.3% | -88.9% |
MIRM Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +358.2% | -98.1% | +1274.2% | -95.8% | at low |
| 5 y | 5 years | at high | +358.2% | -98.1% | +1274.2% | -95.8% | at low |
| alltime | all time | at high | +358.2% | -98.1% | +1274.2% | -95.8% |
Mirum Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.86 M(-47.0%) | $14.14 M(-93.5%) |
| June 2024 | - | $7.29 M(+505.1%) | $217.40 M(-33.1%) |
| Mar 2024 | - | $1.21 M(-32.2%) | $324.82 M(-3.5%) |
| Dec 2023 | $336.60 M(+208.6%) | $1.78 M(-99.1%) | $336.60 M(+0.6%) |
| Sept 2023 | - | $207.13 M(+80.6%) | $334.49 M(+56.7%) |
| June 2023 | - | $114.71 M(+783.2%) | $213.43 M(+105.3%) |
| Mar 2023 | - | $12.99 M(-4047.4%) | $103.97 M(-4.7%) |
| Dec 2022 | $109.09 M(+48.5%) | -$329.00 K(-100.4%) | $109.09 M(-0.9%) |
| Sept 2022 | - | $86.07 M(+1540.6%) | $110.03 M(+352.6%) |
| June 2022 | - | $5.25 M(-71.0%) | $24.31 M(-71.4%) |
| Mar 2022 | - | $18.10 M(+2843.7%) | $84.98 M(+15.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $73.47 M(-59.5%) | $615.00 K(+78.3%) | $73.47 M(-64.6%) |
| Sept 2021 | - | $345.00 K(-99.5%) | $207.36 M(-0.8%) |
| June 2021 | - | $65.91 M(+899.6%) | $209.11 M(+46.0%) |
| Mar 2021 | - | $6.59 M(-95.1%) | $143.22 M(-21.0%) |
| Dec 2020 | $181.29 M(+42.5%) | $134.51 M(+6317.4%) | $181.29 M(+287.5%) |
| Sept 2020 | - | $2.10 M(+8284.0%) | $46.78 M(-58.6%) |
| June 2020 | - | $25.00 K(-99.9%) | $113.10 M(-34.2%) |
| Mar 2020 | - | $44.66 M(>+9900.0%) | $171.84 M(+35.1%) |
| Dec 2019 | $127.18 M | $0.00(-100.0%) | $127.18 M(0.0%) |
| Sept 2019 | - | $68.42 M(+16.4%) | $127.18 M(+116.4%) |
| June 2019 | - | $58.76 M(>+9900.0%) | $58.76 M(>+9900.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
FAQ
- What is Mirum Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals annual CFF year-on-year change?
- What is Mirum Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly CFF year-on-year change?
- What is Mirum Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals TTM CFF year-on-year change?
What is Mirum Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of MIRM is $336.60 M
What is the all time high annual CFF for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high annual cash flow from financing activities is $336.60 M
What is Mirum Pharmaceuticals annual CFF year-on-year change?
Over the past year, MIRM annual cash flow from financing activities has changed by +$227.51 M (+208.56%)
What is Mirum Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of MIRM is $3.86 M
What is the all time high quarterly CFF for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high quarterly cash flow from financing activities is $207.13 M
What is Mirum Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, MIRM quarterly cash flow from financing activities has changed by -$203.27 M (-98.13%)
What is Mirum Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of MIRM is $14.14 M
What is the all time high TTM CFF for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high TTM cash flow from financing activities is $336.60 M
What is Mirum Pharmaceuticals TTM CFF year-on-year change?
Over the past year, MIRM TTM cash flow from financing activities has changed by -$320.36 M (-95.77%)